Number of cancer cases linked to breast implants soars

February 7, 2019 By Nancy Crotti Leave a Comment

FDA said it has received reports of 457 unique cancer cases related to breast implants since 2010, including nine patient deaths.

The agency identified those unique cases from a total of 660 adverse event reports in the U.S. from 2010 through September 2018, including 246 new adverse event reports since 2017.

FDA began reporting on cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a type of non-Hodgkin’s lymphoma and a known risk from breast implants, in 2011. The new total of reports is larger than the number of unique cases because patients, providers, and manufacturers may all report an incident, resulting in duplicative reports.

The increase in reports may also be due to heightened FDA efforts to communicate BIA-ALCL risks, an increased understanding of this particular type of cancer, and a more thorough analysis of adverse event reports, according to the agency.

“It is crucial to understand that due to under-reporting and missing data, the FDA is unable to confirm whether this dataset reflects the distribution of all BIA-ALCL cases,” FDA said in a prepared statement.

“We want to provide patients with the most up-to-date information about the variety of breast implants available so that patients and providers can have thorough and thoughtful discussions weighing the benefits and risks of different products,” added Binita Ashar, M.D., of FDA’s Center for Devices and Radiological Health (CDRH), in a separate statement. “We also want to be transparent in sharing the information we regularly gather and analyze in a way that provides important context to help inform these discussions…

“We hope that this information prompts providers and patients to have important, informed conversations about breast implants and the risk of BIA-ALCL,” continued Ashar, who is director of CDRH’sDivision of Surgical Devices. “At the same time, we remain committed to working in partnership with all stakeholders to continue to study, understand and provide updates about this important public health issue.”

Ashar also acknowledged the regulatory actions of FDA counterparts in different countries in response to reports of BIA-ALCL cases. Allergan (NYSE: AGN) removed its textured breast implants from the market in Europe in December, following a request from French regulators. The New York Times reported that the implants were linked to an uncommon form of lymphoma that can arise years after the implant is placed.

“The different devices approved in each country, availability of products, variation in market share, extent of medical device adverse event reporting, and availability of information regarding the total number of implants sold differs from country to country,” Ashar said. “This makes it difficult for the regulatory bodies of different countries to compare data and determine risk rates on a global scale…

“We recognize the limitations of medical device reports, which is why we review other sources of information, including medical literature and the Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE).”

PROFILE collects real-world data regarding patients who have a confirmed diagnosis of BIA-ALCL.

FDA also said it is issuing a letter to healthcare providers to encourage those who regularly treat patients, including primary care physicians and gynecologists, to learn about BIA-ALCL in patients with breast implants. BIA-ALCL will be discussed at a public meeting of the FDA’s General and Plastic Surgery Devices Panel at its headquarters in Silver Spring, Md. on March 25-26.

3M posts wider-than-forecast losses in Q4 results, will cut 1,500 jobs
3M (NYSE:MMM) posted fourth-quarter results today that matched the revenue consensus forecast on Wall Street but significantly missed on earnings — with the company announcing plans to cut 1,500 jobs amid a reorganization. 3M Healthcare Q4 sales were up 25.4% year-over-year. The Maplewood, Minn.–based company reported profits of $969 million, or $1.66 per share, on… […]
MIT researchers develop light-based device to measure blood glucose
Scientists at the Massachusetts Institute of Technology (MIT) have shown that they can use a type of spectroscopy to replace finger sticks to measure blood glucose levels. Patients with diabetes must test those levels several times a day and more than half of patients don’t test often enough, in part because of the pain and… […]
Soliton touts scar treatment study results
Soliton (NSDQ:SOLY) today announced positive results from treatment of fibrotic scars using its rapid acoustic pulse (RAP) device. The proof-of-concept study, conducted 12 weeks after a single treatment with the device, showed that 10 patients’ keloid and hypertrophic scars were with smaller. Soliton licensed the technology from the University of Texas on behalf of the… […]
January 2020 Issue: The Leadership in Medical Technology Issue
Miles White’s fearless strategy for growing Abbott CVRx CEO Nadim Yared keeps his edge The 10 greatest medtech advances of the 2010s I’m a medtech expert who survived a tumor in my head The next Roaring ’20s The medtech industry received one of the best holiday gifts it could have hoped for just before Congress… […]
Integer adds IPG manufacturing and testing tech to Mexico plant
Integer Holdings (NYSE:ITGR) announced it has added implantable pulse generator (IPG) cleanroom assembly and testing capabilities at its Tijuana-North facility. The plant is the first Class III active-implantable medtech manufacturing site in Mexico to receive FDA approval, according to the Plano, Texas-based company. Integer has added Class 7 and 8 cleanrooms, and manufacturing and capital… […]
FDA issues draft guidance on multi-use arthroscopy tubing sets
The FDA has issued draft guidance on arthroscopy pump tubing sets intended for multiple-patient use. Clinicians often use a single source of irrigation fluid for multiple patients without replacing the source of irrigation fluid or replacing/reprocessing the irrigation tubing system between patients. These devices are designed to deliver irrigation to the surgical site, these devices… […]
How LED light can break down ingestible medical devices
Researchers at the Massachusetts Institute of Technology have developed an approach to break down ingestible medical devices in the gastrointestinal tract. Medical devices can be inserted in the gastrointestinal tract to treat, diagnose or monitor a number of GI disorders. However, the devices have to removed through endoscopic surgery once completed. The MIT researchers developed… […]
New 510(k) boosts iRhythm, Verily efforts for AFib screening
The latest 510(k) clearance for the Verily Study Watch will further the efforts of the Google sister company and iRhythm Technologies (NSDQ:IRTC) to improve atrial fibrillation treatment. Verily — a life science company under Alphabet (NSDQ:GOOGL) — recently received an FDA 510(k) clearance to include an irregular pulse monitor in its Study Watch wearable. “We’ve worked carefully to meet the FDA’s stringent… […]
Argon Medical debuts IVC filter retrieval kits
Argon Medical Devices (Frisco, Texas) said this week that it has launched single-loop and triple-loop retrieval kits for percutaneous removal of inferior vena cava (IVC) filters that are no longer medically required. The kits are indicated for use via a jugular approach and offer the following features: A coil-reinforced outer sheath with the strength needed… […]
NANS 2020: Neuromodulation news you need to know
Neuromodulation devices from companies including Medtronic (NYSE:MDT), Abbott (NYSE:ABT) and SPR Therapeutics are showing promise treating pain. That’s one of the initial takeaways from study results that medical device companies in the neuromodulation space are touting this weekend at NANS 2020 in Las Vegas. NANS is a joint conference of Congress of Neurological Surgeons and the North American Neuromodulation… […]
Injection Molding Principles
Optimizing custom part designs for injection molding requires a thorough understanding of the process and outcomes. In this e-book, you’ll learn about common molding resins, special molding terms you should know, and most importantly, how to optimize your part with undercuts, even walls, drafts, and more. Download this e-book from Xometry to learn more… The […]